Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials

Takumi Kawaguchi(Kurume University), Takuji Torimura(Omuta hospital), Tsubasa Tsutsumi(Kurume University), Sakura Yamamura(Kurume University), Michael Charlton(Madrigal Pharmaceuticals (United States)), Maryam Zafer(University of California, San Francisco), Atsushi Kawaguchi(Kyoto University), Dan Nakano(Kurume University)
Seminars in Liver Disease
June 19, 2021
10.1055/s-0041-1723751
Cited by 118

Related Papers

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536